All-Trans Retinoic Acid plus Arsenic Trioxide was superior to ATRA-chemotherapy in event-free survival high-risk acute promyelocytic leukaemia.
Future hepatologists could have numerous drugs for MASLD control and treatment. Promising results from recent trials were presented at EASL 2024.
During EASL 2024, the rise of AI in radiology and liver pathology; and of multisystem / multiscale integration in HCC patient care was discussed.
AI is revolutionizing many fields, including hepatology. During EASL 2024, its clinical application was discussed, with a focus on personalized patient management.
Which diagnostic and treatment pathways for MASLD patients will exist in 2030? Dr. Ian Rowe discusses patient management scenarios in the near future.
A symposium addressed chronic viral hepatitis management in children, and whether all children with chronic viral hepatitis should be treated.
Liver diseases expert Prof. Umberto Vespasiani-Gentilucci addresses important innovations in disease management with a focus on PBC and ‘real world’ data use.
Physician and medical historian Dr Lea Münch looked into psychiatric patients' treatment during the Nazi occupation of Alsace, from the patients' point of view.
AML reveals a complex interplay between malignant cells and their environment where disease progression and treatment response is orchestrated.
The journey to unravelling the complexities of AML treatment, especially in intermediate-risk patients, evolves as novel diagnositcs and therapies are embraced.
Besides WHO's classification, ICC's system for AML diagnosis and treatment is also available since 2022. How do they differ and which should be followed?
A type 2 diabetes drug slowed the progression of Parkinson's disease symptoms, according to a French study testing lixisenatide effects on 156 patients.
A new study showed that VR provided greater pain relief than control in adult patients with moderate-to-severe pain related to cancer and its therapies.
The standard treatment for scabies is permethrin, but it is becoming less due to mutations in the scabies mite that have led to resistance development.
Some Crohn's disease or ulcerative colitis patients do not respond to infliximab or its effect diminish for them. This could be related to visceral fat mass.
BRCA1 and BRCA2 mutations are crucial in hereditary breast and ovarian cancer treatment and prevention. Finding suitable germline-analysis patients is hard.
A study hints that e-cigarettes cause the same epigenetic changes found in cancer patients and traditional cigarette smokers. But the study has many limitations.
Cervical cancer is one of the most common forms of cancer in women. Various surgical and conservative treatments exist, but which therapy is suitable for which patient?
In breast cancer, metastases may occur in body areas not always easy to treat. But there are two new treatment options for these patients.
Oral contraceptives have a significant impact on hormonal balance. But they may also alter emotional regulation and enhance anxiety disorders.